Kun-Hsing Yu

Dr. Kun-Hsing Yu is a pathomics researcher at Harvard Medical School who applies deep learning to extract prognostic features from H&E whole slide images. He has demonstrated that AI-derived histologic features predict molecular subtypes and survival outcomes in colorectal, breast, and lung cancers without the need for molecular profiling. His pathomics research integrates computational pathology with genomic and clinical data for comprehensive AI-based cancer characterization.